Literature DB >> 15892157

Prognostic significance of alarm symptoms in patients with gastric cancer.

M R Stephens1, W G Lewis, S White, G R J C Blackshaw, P Edwards, J D Barry, M C Allison.   

Abstract

BACKGROUND: The aim of this study was to determine the incidence and spectrum of alarm symptoms in patients with newly diagnosed gastric cancer, and to examine the relationship between symptoms and outcome.
METHODS: Three hundred consecutive patients with gastric adenocarcinoma were studied prospectively. The outcomes of 40 patients (13.3 per cent) without alarm symptoms (21 men; median age 69 years) were compared with those of the 260 patients (86.7 per cent) with alarm symptoms (175 men; median age 72 years).
RESULTS: It was possible to perform an R0 gastrectomy more often in patients without alarm symptoms (21 patients; 52 per cent) than in those with alarm symptoms (71 patients; 27.3 per cent) (chi(2) = 10.35, 1 d.f., P = 0.001). The cumulative survival rate at 5 years was 38 per cent for patients without alarm symptoms versus 15.0 per cent for those with alarm symptoms (chi(2) = 10.18, 1 d.f., P = 0.001). In a multivariate analysis, distant metastasis (hazard ratio (HR) 2.73 (95 per cent confidence interval (c.i.) 2.04 to 3.66); P < 0.001), overall stage of cancer (HR 1.83 (95 per cent c.i. 1.53 to 2.19); P < 0.001) and persistent vomiting at diagnosis (HR 1.66 (95 per cent c.i. 1.26 to 2.18); P < 0.001) were independently associated with length of survival.
CONCLUSION: Alarm symptoms are absent in a significant minority of patients with gastric cancer at diagnosis; these patients stand a better chance of curative surgery and long-term survival than those with alarm symptoms. Copyright 2005 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892157     DOI: 10.1002/bjs.4984

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

1.  Body mass index and mortality in patients with gastric cancer: a large cohort study.

Authors:  Jung Hwan Lee; Boram Park; Jungnam Joo; Myeong-Cherl Kook; Young-Il Kim; Jong Yeul Lee; Chan Gyoo Kim; Il Ju Choi; Bang Wool Eom; Hong Man Yoon; Keun Won Ryu; Young-Woo Kim; Soo-Jeong Cho
Journal:  Gastric Cancer       Date:  2018-04-12       Impact factor: 7.370

2.  Perioperative chemotherapy for gastroesophageal cancer in British Columbia: a multicentre experience.

Authors:  R D Peixoto; W Y Cheung; H J Lim
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

3.  Upper gastrointestinal cancer in its early stages is predominantly asymptomatic.

Authors:  James W Berrill; Jeff K Turner; Jo J Hurley; Gillian Swift; Sunil Dolwani; John T Green
Journal:  Frontline Gastroenterol       Date:  2011-09-10

Review 4.  Role of symptoms in diagnosis and outcome of gastric cancer.

Authors:  Giovanni Maconi; Gianpiero Manes; Gabriele-Bianchi Porro
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

5.  Role of gastric bypass in patients with unresectable advanced carcinoma of stomach.

Authors:  Nagarjuna V Maturu; Dinker R Pai; Vishnu N R Prasad
Journal:  Indian J Surg       Date:  2008-12-23       Impact factor: 0.656

6.  Role of gastric bypass in patients with unresectable advanced carcinoma of stomach.

Authors:  Nagarjuna V Maturu; Dinker R Pai; Vishnu N R Prasad
Journal:  Indian J Surg       Date:  2008-01-28       Impact factor: 0.656

7.  MARK's Quadrant scoring system: a symptom-based targeted screening tool for gastric cancer.

Authors:  Mahadevan D Tata; Ramesh Gurunathan; Kandasami Palayan
Journal:  Ann Gastroenterol       Date:  2014

8.  A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer.

Authors:  Qun-Xiong Pan; Zi-Jian Su; Jian-Hua Zhang; Chong-Ren Wang; Shao-Ying Ke
Journal:  Onco Targets Ther       Date:  2015-06-17       Impact factor: 4.147

Review 9.  Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence.

Authors:  Minjoung M Koo; William Hamilton; Fiona M Walter; Greg P Rubin; Georgios Lyratzopoulos
Journal:  Neoplasia       Date:  2017-12-16       Impact factor: 5.715

10.  Comparison of Treatment Modalities for Locally Advanced Gastric Cancer: A Propensity Score Matching Analysis.

Authors:  Jianglong Han; Zhihua Nie; Ping Li; Hongwei Shi; Shijie Wang; Qin Li; Rui Zhang; Yunfeng Qiao; Kejie Huang; Zhenming Fu
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.